# Metabolic Manipulation in Chronic Heart Failure

> **NCT00841139** · PHASE2 · COMPLETED · sponsor: **University Hospital Birmingham NHS Foundation Trust** · enrollment: 50 (actual)

## Conditions studied

- Chronic Heart Failure

## Interventions

- **DRUG:** Perhexiline
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00841139
- **Lead sponsor:** University Hospital Birmingham NHS Foundation Trust
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-02
- **Primary completion:** 2011-09
- **Final completion:** 2011-09
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2011-11-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00841139

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00841139, "Metabolic Manipulation in Chronic Heart Failure". Retrieved via AI Analytics 2026-09-22 from https://api.ai-analytics.org/clinical/NCT00841139. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*